Listar por autor "Levy‑Naon, Alberto"
Mostrando ítems 1-2 de 2
-
Cost-effectiveness of omalizumab in severe persistent asthma in Spain: a real-life perspective.
Levy‑Naon, Alberto; García-Ruiz, Antonio J.
; García-Agua-Soler, Nuria; Hidalgo Sanjuan, Mª Victoria (Taylor & Francis, 2014-11-24)
Objectives: To determine the cost-effectiveness of omalizumab compared with routine clinical practice in the treatment and control of severe persistent asthma. Methods: Cost-effectiveness analysis using pre- and ... -
Real‑life cost‑effectiveness of benralizumab in patients with severe asthma.
Padilla‑Galo, A.; García-Ruiz, Antonio J.; Levy Abitbol, R. Ch.; Olveira-Fuster, Casilda; Rivas‑Ruiz, F; García-Agua-Soler, Nuria; Pérez Morales, Marcel; Valencia Azcona, B.; Tortajada‑Goitia, B.; Moya‑Carmona, Isabel; Levy‑Naon, Alberto[et al.] (BMC, 2021-05-27)
The aim of this study was to evaluate clinical outcomes and healthcare expenditure after incorporating benralizumab into the standard treatment of refractory eosinophilic asthma. Methods: This was a cross-sectional ...